{
  "content": "GE Kochiadakis et al.\n\nLong-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses\nChest (2004)\n\nBN Singh et al.\n\nAmiodarone versus sotalol for atrial fibrillation\nN Engl J Med (2005)\n\nSJ Connolly et al.\n\nComparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial\nJAMA (2006)\n\nJanuary CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC, Conti JB, Ellinor PT, Ezekowitz MD, Field ME,...\nSM Al-Khatib et al.",
  "source": "https://www.sciencedirect.com/science/article/abs/pii/S000291491931046X",
  "chunk_id": "a339354e-d19d-4fe2-99f1-2778b5a297ab",
  "similarity_score": 0.36776483058929443,
  "query": "atrial fibrillation recurrence rates maintenance therapy amiodarone beta-blockers long-term outcomes rhythm maintenance",
  "rank": 36,
  "title": "Meta-Analysis Comparing the Relative Risk of Adverse Events for Amiodarone Versus Placebo",
  "authors": "Mohammed Ruzieh, Morgan K. Moroi, Nader M. Aboujamous, Mehrdad Ghahramani, Gerald V. Naccarelli, John Mandrola, Andrew J. Foy",
  "year": "2019",
  "journal": "The American Journal of Cardiology",
  "reference": "Ruzieh, M., Moroi, M. K., Aboujamous, N. M., Ghahramani, M., Naccarelli, G. V., Mandrola, J., & Foy, A. J. (2019). Meta-analysis comparing the relative risk of adverse events for amiodarone versus placebo. The American Journal of Cardiology, 124(12), 1889-1893.",
  "doi": "Not available",
  "chunk_index": 7,
  "total_chunks": 21,
  "retrieved_at": "2025-07-24T21:58:13.326336"
}